Graham Capital Management L.P. Makes New Investment in Ardent Health, Inc. $ARDT

Key Points

• Graham Capital Management L.P. acquired a new stake in Ardent Health, Inc., purchasing 43,498 shares valued at approximately $598,000 in the first quarter.
• Vanguard Group Inc. significantly increased its stake by 368.9%, owning 1,330,635 shares worth $18,296,000 following the acquisition of over a million additional shares.
• Ardent Health's stock is currently trading at $13.19, and the company recently reported earnings of $0.52 per share, surpassing analysts' expectations.

Graham Capital Management L.P. purchased a new stake in shares of Ardent Health, Inc. (NYSE:ARDT - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 43,498 shares of the company's stock, valued at approximately $598,000.

Several other large investors have also made changes to their positions in the business. Quarry LP boosted its stake in shares of Ardent Health by 1,519.4% in the first quarter. Quarry LP now owns 5,020 shares of the company's stock worth $69,000 after acquiring an additional 4,710 shares during the period. State of Wyoming lifted its holdings in Ardent Health by 25.7% in the 1st quarter. State of Wyoming now owns 39,851 shares of the company's stock worth $548,000 after purchasing an additional 8,158 shares in the last quarter. Trexquant Investment LP bought a new position in Ardent Health in the 1st quarter worth approximately $1,537,000. Corebridge Financial Inc. grew its holdings in Ardent Health by 91.6% during the 1st quarter. Corebridge Financial Inc. now owns 11,687 shares of the company's stock valued at $161,000 after buying an additional 5,586 shares in the last quarter. Finally, MetLife Investment Management LLC raised its position in shares of Ardent Health by 98.4% during the first quarter. MetLife Investment Management LLC now owns 14,622 shares of the company's stock valued at $201,000 after buying an additional 7,253 shares during the last quarter.

Analyst Ratings Changes

ARDT has been the subject of a number of research reports. Royal Bank Of Canada restated an "outperform" rating and set a $21.00 target price on shares of Ardent Health in a research report on Thursday, May 15th. UBS Group began coverage on Ardent Health in a report on Wednesday. They issued a "buy" rating and a $17.00 target price on the stock. Stephens reiterated an "overweight" rating and issued a $21.00 target price on shares of Ardent Health in a research report on Tuesday, May 20th. Wall Street Zen upgraded Ardent Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 9th. Finally, Bank of America downgraded Ardent Health from a "neutral" rating to an "underperform" rating and reduced their price objective for the stock from $15.50 to $14.60 in a research note on Wednesday, July 16th. Nine equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $19.33.

Ardent Health Trading Up 1.6%

Shares of NYSE:ARDT traded up $0.21 during trading on Thursday, hitting $13.24. The company had a trading volume of 336,891 shares, compared to its average volume of 271,535. The stock has a market cap of $1.89 billion, a price-to-earnings ratio of 7.31, a price-to-earnings-growth ratio of 5.76 and a beta of 0.30. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.13 and a quick ratio of 2.00. The company has a fifty day simple moving average of $12.32 and a two-hundred day simple moving average of $13.15. Ardent Health, Inc. has a one year low of $10.10 and a one year high of $20.72.

Ardent Health (NYSE:ARDT - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.30 by $0.22. The company had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.54 billion. Ardent Health had a return on equity of 16.66% and a net margin of 4.11%. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. As a group, equities analysts forecast that Ardent Health, Inc. will post 1.23 earnings per share for the current year.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.